During the course of Trypanosoma brucei brucei infection, a complex interaction occurs between host immune responses and parasite survival strategies. Like other African trypanosomes, T. brucei brucei evade the host's immune responses by constantly modifying their variant surface glycoproteins (VSG) to establish a chronic infection [1, 2] . This phenomenon has hampered the design of an effective antitrypanosome vaccine. Consequently, characterizing the mechanisms that govern resistance and/or susceptibility to trypanosomosis rather than targeting the parasite, could suggest interventions that might lead to disease control, sterile immunity, or vaccination.
During the course of Trypanosoma brucei brucei infection, a complex interaction occurs between host immune responses and parasite survival strategies. Like other African trypanosomes, T. brucei brucei evade the host's immune responses by constantly modifying their variant surface glycoproteins (VSG) to establish a chronic infection [1, 2] . This phenomenon has hampered the design of an effective antitrypanosome vaccine. Consequently, characterizing the mechanisms that govern resistance and/or susceptibility to trypanosomosis rather than targeting the parasite, could suggest interventions that might lead to disease control, sterile immunity, or vaccination.
Various animal models have provided conflicting evidence regarding the immunologic factors that influence the magnitude of resistance to African trypanosomosis. The overall host response to this disease requires the contribution of VSG-specific B and T cell responses [3] [4] [5] and the macrophage/monocyte phagocyte system [6] [7] [8] to resolve the infection. In addition, several studies suggest that cytokine responses influence the outcome of African trypanosomosis [4, [9] [10] [11] [12] [13] . However, the precise role of individual cytokines in trypanotolerance remains unclear and may depend on the animal model, the parasite strain, or both.
Most reports indicate that type I cytokine responses confer resistance to African trypanosome infection by limiting parasite growth during the early stage of infection [4, 9, 14, 15] . Although interferon (IFN)-g has been linked with resistance to Trypanosoma brucei rhodesiense [4, 5] , Uzonna et al. [9, 16] correlated this cytokine with susceptibility to Trypanosoma congolense infection and associated resistance to interleukin (IL)-12-dependent synthesis of IgG2a antibodies against parasite antigens and increased tumor necrosis factor (TNF) secretion. However, sustained secretion of these type I cytokines may be harmful to the host and thereby promote disease progression [13, 14, 17] . Type II cytokines, such as IL-4, have been linked with resistance to African trypanosome infection in cattle [12, 18] and mice [10, 11, 19] via the induction of IgG1 antibodies. However, others claimed a nonprotective or disease-promoting role of type II cytokines [4, 9, 20] .
We recently reported that, after infection with phospholipase C T. brucei brucei null mutant (PLC Ϫ/Ϫ ), (Balb/c ϫ C57Bl) F1 mice and their parental strains exhibited a resistant phenotype with lower parasitemia and prolonged survival (у5 months), unlike equivalent wild-type (wt) infected mice, which die within 5 weeks [11] . In this model, the resistance correlated with the ability of PLC Ϫ/Ϫ -infected animals to produce IFN-g and TNF in response to mitogens or VSG in the early phase of infection, which was followed by the secretion of IL-4 and IL-10 in the late and chronic stages of the disease. The protective role of type II cytokines produced by late-stage PLC Ϫ/Ϫ -infected animals may result from the induction of IgG1 antibody, which leads to parasite control and to the suppression of possible harmful immune responses that result from overproduction of type I cytokines. Because no direct role for IFN-g and IL-10 in the resistance to T. brucei brucei was demonstrated, we in- Experimental design. At each postinfection time interval, levels of cytokines and nitric oxide (NO) were quantified in plasma or culture supernatants of lymphoid cells from 3 infected mice. For each parameter, results were expressed as the mean response of the 3 infected animals tested individually (‫ע‬SE) and were compared with the same parameters assessed in 3 noninfected mice. Results are representative of у2 similar independent experiments. We used the Student's t test to validate data.
Plasma collection and cell cultures. At different times after infection, blood collected by heart puncture on heparin (20 U/mL; Sigma) was centrifuged (10,000 g, 10 min), and the plasma was stored at Ϫ80ЊC. Spleen, mesenteric, and peripheral (axial and inguinal) lymph node single-cell suspensions were prepared as described elsewhere [22] . Also, at different times after infection, spleen or 6 2 ϫ 10 lymph node cells from infected (SPCi and LNCi) or noninfected animals (SPCn and LNCn) were stimulated ex vivo with or without concanavalin A (ConA, 2.5 mg; Sigma) in 1 mL (24-well plates) of RPMI supplemented with fetal calf serum (10%), penicillin-streptomycin (100 U-100 mg/mL), L-glutamine (2 mM), and 2-mercaptoethanol ( M). Cultures were incubated at 37ЊC in a humidi-
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5 ϫ 10 fied atmosphere containing 5% CO 2 , and culture supernatant fluids were collected and frozen at Ϫ80ЊC until analysis.
Quantification of cytokines. Cytokines were quantified in plasma or cell-free culture supernatants. Specific sandwich ELISAs for IFNg, IL-4, IL-10 (PharMingen), or TNF (R&D Systems) were performed, according to the manufacturer's suggested protocols. Concentrations of IL-4 were determined in 24-h cell culture supernatants, and concentrations of IFN-g, TNF, or IL-10 were determined in 72-h cell culture supernatants.
Quantification of NO. Plasma NO levels were determined by quantifying nitrites, as described elsewhere [23] . All reagents were obtained from Sigma. In brief, nitrate was stoichiometrically reduced to nitrite by incubating 100 mL of plasma sample (1 h, 37ЊC) in the presence of Aspergillus NAD[P]H (EC 1.6.6.2, 0.1 U/mL), reduced NADPH (120 mM), and flavine adenine dinucleotide (5 mM). Subsequently, excess NADPH was oxidized with L-lactic dehydrogenase (EC 1.1.1.27, type XI from rabbit muscle; 10 U/mL) and sodium pyruvate (10 mM) for 30 min at 37ЊC. Nitrite concentration in plasma then was assayed by standard Griess reaction [24] .
Results

Parasitemia and survival time of IFN-g
Ϫ/Ϫ and IL-10 Ϫ/Ϫ mice infected with T. brucei brucei. Infection with wt T. brucei brucei resulted in the death of control C57Bl/6 mice at ∼36 days postinfection (dpi), whereas the survival time was reduced to 21 and 8 days in IFN-g Ϫ/Ϫ and IL-10 Ϫ/Ϫ mice, respectively (table  1) . To determine whether the earlier mortality of infected IFNg Ϫ/Ϫ or IL-10 Ϫ/Ϫ mice was linked to an increased parasite burden, parasitemia was evaluated in the course of infection. The first peak of parasitemia occurred 5 dpi, then (except in IFNg Ϫ/Ϫ mice) parasite burden dropped below the detection limit ( /mL) until the animals died. Table 1 shows that, after 4 5 ϫ 10 infection with wt parasites, the parasite density at the first peak of parasitemia was significantly higher in IFN-g Ϫ/Ϫ mice (P ! ) but was similar in IL-10 Ϫ/Ϫ mice and control mice. These .01 data suggest that, although IFN-g may be important for parasite control, IL-10 seems to be more critical than IFN-g for the survival of T. brucei brucei-infected mice.
ConA-induced IFN-g, IL-10, and IL-4 production by lymph node and spleen cells from IFN-g
Ϫ/Ϫ and IL-10 Ϫ/Ϫ mice infected with T. brucei brucei. Cytokines were quantified in culture supernatants of lymph node and spleen cells from wt T. brucei brucei-infected mice (LNCi and SPCi) 6 dpi (i.e., before infected IL-10 Ϫ/Ϫ mice died; see table 1 ). In nonstimulated cell cultures, only IFN-g was detected in LNCi supernatants of infected control mice ( pg/mL). We found higher levels of IFN-g ). SPCi of infected IL-10 Ϫ/Ϫ mice also spontaneously P ! .05 secreted IFN-g ( pg/mL). 3 2 ϫ 10 ConA-induced IFN-g secretion was up-regulated in LNCi supernatants from control and IL-10 Ϫ/Ϫ mice, compared with lymph node cell supernatants from equivalent uninfected mice (LNCn; figure 1 ). The IFN-g levels were higher in infected IL-10 Ϫ/Ϫ mice than in infected control mice ( ). In agreement P ! .05 with our previous report [11] , ConA-induced IFN-g production was impaired in SPCi from wt-infected control mice, compared with splenocytes from noninfected control mice (SPCn; figure  1; ). In IL-10 Ϫ/Ϫ mice, IFN-g levels in SPCi supernatants P ! .01 from infected mice were not significantly modulated, compared with SPCn, although they tended to be up-regulated.
Unlike the ConA-stimulated LNCn that produced marginal levels of IL-10, LNCi from wt-infected control mice and to a lesser extent from wt-infected IFN-g Ϫ/Ϫ mice secreted increased amounts of this cytokine ( ; figure 1) . ConA-activated P ! .01 SPCi supernatants from control and IFN-g Ϫ/Ϫ mice infected with wt parasites showed modulations of IL-10 secretion similar to LNCi supernatants (figure 1). IL-4 was not detected in ConA-stimulated lymph node or spleen cell supernatants from uninfected or wt-infected mice in any of the 3 mouse strains. These data indicate that infection of IL-10 Ϫ/Ϫ mice with T. brucei brucei correlates with increased IFN-g secretion. Moreover, type II cytokines are not up-regulated in T. brucei bruceiinfected IFN-g Ϫ/Ϫ mice.
Plasma levels of IFN-g, IL-10, and IL-4 in IFN-g
Ϫ/Ϫ and IL-10 Ϫ/Ϫ mice infected with T. brucei brucei. Levels of IFN-g, IL-10, and IL-4 in the plasma of IFN-g Ϫ/Ϫ and IL-10 Ϫ/Ϫ mice infected with wt parasites were determined at 6 dpi. IFN-g levels increased in both infected control and IL-10 Ϫ/Ϫ mice, compared with those in equivalent uninfected mice ( ; P ! .01 figure 2 ). These levels were significantly higher in infected IL-10 Ϫ/Ϫ mice than in infected control mice ). IL-10 levels (P ! .01 only were increased in the plasma of wt-infected control mice (not in uninfected mice; figure 2; ), and IL-4 was absent P ! .01 in the plasma of the 3 mouse strains, even after infection. These results corroborate the cytokine profiles observed in the lymph node and spleen compartments of T. brucei brucei-infected mice and indicate that the absence of IL-10 correlates with increased IFN-g secretion. In addition, the absence of IFN-g Ϫ/Ϫ does not result in increased type II cytokine production.
Plasma levels of TNF and NO in IFN-g Ϫ/Ϫ and IL-10 Ϫ/Ϫ mice infected with T. brucei brucei. Plasma levels of TNF and NO (measured as accumulation of nitrites) reflecting the state of macrophage activation [25] were quantified in IFN-g Ϫ/Ϫ and IL-10 Ϫ/Ϫ mice infected with T. brucei brucei (figure 3). Infection with wt parasites triggered significantly increased plasma levels of TNF and NO in control and IL-10 Ϫ/Ϫ mice ( ) but not P ! .01 in IFN-g Ϫ/Ϫ mice, compared with those in uninfected mice. Moreover, TNF and NO levels were higher in the plasma of infected IL-10 Ϫ/Ϫ mice than in infected control mice ( ). P ! .01 These observations indicate that, in T. brucei brucei-infected mice, macrophages are minimally activated in the absence of IFN-g but are hyperactivated in the absence of IL-10. . Noninfected control or IL-10 Ϫ/Ϫ mice had similar plasma levels of IFN-g ( pg/ mean ‫ע‬ SE n p 3 220 ‫ע‬ 100 mL). Plasma IL-10 levels in noninfected control mice were pg/mL. 3 ‫ע‬ 2
Possible regulatory role of IL-10 on IFN-g secretion during T. brucei brucei infection.
To investigate a possible cross-regulation of IFN-g and IL-10 production [26] in T. brucei brucei infection, plasma levels were evaluated daily during the first week of wt trypanosome infection. Figure 4 shows that 2 peaks of IFN-g production occurred during infection of control mice with wt T. brucei brucei at 1, and 5 dpi which coincided with the first peak of parasitemia. A burst in IL-10 secretion followed each peak of IFN-g production after a 1 or 2 days, which corresponded with the reduction of IFN-g levels. In IL-10 Ϫ/Ϫ mice, the levels of IFN-g in plasma from wt-infected mice uncontrollably increased until the animals died (figure 4). These data suggest that IL-10 regulates the secretion of IFN-g and highlights the potential detrimental effect of sustained production of IFNg for host survival during murine African trypanosomosis.
Contribution of CD4 ϩ and CD8 ϩ T cells to IFN-g and IL-10 production in mice infected with T. brucei brucei. The contribution of CD4
ϩ and CD8 ϩ T cells to IFN-g and IL-10 production during T. brucei brucei infection was investigated at 6 dpi (figure 5). Infection with wt parasites resulted in similar increased plasma levels of IFN-g in control and CD4 Ϫ/Ϫ mice. In contrast to the latter, IFN-g levels were reduced in CD8 Ϫ/Ϫ mice ( ), although they remained up-regulated, compared P ! .01 with those in uninfected mice ( ). P ! .05
Control and CD8
Ϫ/Ϫ mice infected with wt parasites had similar levels of IL-10 in their plasma. These levels were significantly increased, compared with those in noninfected mice ( figure 5; ). Of interest, IL-10 levels were not modulated in the P ! .01 plasma of wt-infected CD4 Ϫ/Ϫ mice. Concerning the possible influence of CD4 ϩ and CD8 ϩ T cells on resistance to infection, we observed that, during wt trypanosome infection, CD4
Ϫ/Ϫ mice tended to have lower survival times than did the control mice, whereas CD8 Ϫ/Ϫ mice had an ∼2-fold increased survival time (table 2) . There was no significant difference in the parasitemia of wt-infected CD4 Ϫ/Ϫ mice infected with PLC Ϫ/Ϫ parasites were significantly higher than those in uninfected mice ( ) but remained lower P ! .05 than those in wt-infected equivalent mice ( ; figure 5 ). Cor-P ! .01 respondingly, the 3 mouse strains infected with PLC Ϫ/Ϫ trypanosomes displayed a more resistant phenotype than did equivalent wt-infected mice (longer survival, lower parasite load; table 2). However, the higher IL-10 levels in PLC 
CD8
Ϫ/Ϫ mice than in wt-infected control or CD8 Ϫ/Ϫ mice (figure 5;
) corresponded with a resistant phenotype (table 2). Con-P ! .01 versely, the absence of IL-10 in plasma correlated with reduced survival of PLC
Ϫ/Ϫ mice ( figure 5; table 2 ).
Discussion
In a recent report, resistance to T. brucei brucei infection in mice was suggested to correlate with a sequential switch from type I cytokine production (IFN-g and/or TNF) during the early stage of infection to type II cytokine production (IL-10 and/or IL-4) during the late stage of infection [11] . However, a direct role for type I or type II cytokines in resistance to extracellular T. brucei brucei parasites was not demonstrated. Therefore, we investigated the contributions of IFN-g and IL-10 to T. brucei brucei infection by using IFN-g Ϫ/Ϫ and IL-10 Ϫ/Ϫ C57Bl/6 mice. IFN-g production is associated with the relative susceptibility of mice (high parasitemia and decreased survival) to T. congolense infection [16] . However, resistance to T. brucei rhodesiense infection (low parasitemia and increased survival) is IFN-g dependent [4, 27] . Our observations support the suggested protective role for IFN-g during murine T. brucei infection. In contrast to the control mice, survival time was significantly reduced and the parasite load increased ∼2-fold in IFN-g Ϫ/Ϫ mice after infection with wt T. brucei brucei. These results were corroborated in the PLC Ϫ/Ϫ T. brucei brucei model. Although PLC Ϫ/Ϫ -infected control mice survived for ∼5 months (table 2) , PLC Ϫ/Ϫ -infected IFN-g Ϫ/Ϫ mice died at ∼ dpi with an 40 ‫ע‬ 5 increased parasitemia ( /mL; authors' unpub-6 129 ‫ע‬ 27 ϫ 10 lished data). The increased IFN-g production during the early stage of infection with T. brucei brucei may elicit macrophages to directly eliminate parasites by phagocytosis [7, 8, 28, 29] . In addition, IFN-g-mediated macrophage activation may result in concomitant increased production of TNF and NO that are trypanolytic and trypanostatic, respectively [8, 17, 23, [30] [31] [32] . Alternatively, IFN-g may act as a switch factor for IgG2a and IgG3 antibody production, which could participate in parasite control [9, 33, 34] .
Results of our study further confirm the role of IFN-g as a prerequisite for TNF and NO secretion [35] , as shown by their greatly reduced levels during infection of IFN-g Ϫ/Ϫ mice. However, the loss of IFN-g does not lead to increased secretion of type II cytokines. This result is in keeping with our previous observations that reduced circulating levels of IFN-g in the plasma of late-stage wt-infected mice is not accompanied by increased type II cytokine production [11] .
Despite the beneficial effects of IFN-g during T. brucei brucei infection, its uncontrolled production may promote the disease [11, 16] . Accordingly, we observed that the dramatic increase in IFN-g production correlated with the decreased survival of IL-10 Ϫ/Ϫ mice after infection with wt parasites. In addition, CD4 Ϫ/Ϫ mice, which produce as much IFN-g as control mice upon infection with either wt or PLC Ϫ/Ϫ T. brucei brucei, had reduced survival and more pathology, including anemia, than did control mice (authors' unpublished data). These observations suggest that sustained IFN-g production, paralleled by increased secretions of TNF and NO and macrophage hyperactivation, results in systemic pathology and reduced survival of T. brucei brucei-infected mice. Moreover, we confirmed that the principal sources of IFN-g during the early phase of T. brucei brucei infection are CD8 ϩ T cells [36] [37] [38] [39] . However, the low levels of IFN-g observed in infected CD8 Ϫ/Ϫ mice suggest that activated NK cells, macrophages, and/or CD3 ϩ Thy1.2
Ϫ cells also may contribute to the early burst of IFN-g secretion [40] [41] [42] .
The absence of IL-10 rendered wt T. brucei brucei-infected mice extremely susceptible and resulted in death within 1 week of infection. Yet, wt-infected CD8 Ϫ/Ϫ mice that had increased circulating levels of IL-10 and markedly reduced levels of IFNg survived longer than did infected control mice. Moreover, PLC
Ϫ/Ϫ mice with increased plasma IFN-g levels and undetectable IL-10 levels died earlier than did infected control mice. Finally, the loss of IL-10 shifted the course of infection from a chronic to an acute lethal disease in PLC Ϫ/Ϫ -infected mice (mean survival days; authors' unpublished data). This 13 ‫ע‬ 1 occurred without further increase in circulating parasite loads. Rather, the early mortality of wt or PLC Ϫ/Ϫ T. brucei bruceiinfected IL-10 Ϫ/Ϫ mice was associated with greatly increased levels of inflammatory molecules (IFN-g, TNF, and NO) and a concomitant depression in IL-4 production in PLC Ϫ/Ϫ -infected mice (authors' unpublished data). Such infected IL-10 Ϫ/Ϫ mice also exhibited pathologic features, such as nervous symptoms, emaciation, anemia, and systemic inflammation (authors' unpublished data). These observations suggest that IL-10 is a critical regulator of the balance between protective and pathogenic cellular immune responses during murine T. brucei brucei infection. Accordingly, the cross-regulation of IFN-g and IL-10 observed in the early stage of wt trypanosome infection suggests a role for IL-10 in the prevention of IFN-g and associated inflammatory mediator (TNF and NO) hypersecretions, as described in Plasmodium chabaudi, Toxoplasma gondii, and Trypanosoma cruzi infections [43] [44] [45] . All these intracellular infections preferentially trigger a strong type I cytokine response that is important for parasite clearance during the early phase of the disease and regulated by IL-10.
The striking reduced survival observed in T. brucei bruceiinfected IL-10 Ϫ/Ϫ mice suggests that other anti-inflammatory cytokines, such as transforming growth factor (TGF)-b, IL-4, or IL-13, do not sufficiently compensate for the loss of IL-10 in this system [46, 47] . Accordingly, we did not observe increased IL-4 production in infected IL-10 Ϫ/Ϫ mice. Expression of IL-4 does not correlate with survival of T. brucei bruceiinfected mice [19] . Moreover, no difference in the induction of TGF-b was observed between T. brucei brucei-resistant and susceptible mice [48] . The absence of IL-10 in CD4 Ϫ/Ϫ mice and the increased plasma IL-10 in CD8 Ϫ/Ϫ mice also suggest that CD4 ϩ T cells are essential, directly or indirectly, via macrophage, CD5 ϩ B cell, or CD3 ϩ Thy1.2 ϩ ab Ϫ gd Ϫ CD4 Ϫ CD8 Ϫ cell activation for early IL-10 production in T. brucei bruceiinfected mice [42, 49, 50] .
Of interest, administration of anti-IFN-g or anti-IL-10 antibodies decreases parasitemia and prolongs the lives of T. congolense-infected mice, which suggests that the 2 cytokines contribute to susceptibility [16, 20] . Our present data strongly suggest that, although IFN-g is involved in the control of T. brucei brucei parasitemia, IL-10 is essential for survival, possibly by limiting excessive inflammatory responses. T. congolense remains exclusively in the blood, whereas T. brucei brucei invades blood and lymphoid tissues. Thus, the mechanisms of protection against T. congolense and T. brucei brucei, because of their different location in the host, may differ; therefore, this issue requires further elucidation.
In summary, our study results reinforce our previous observations that suggested that resistance to T. brucei brucei infection requires a temporal activation of pro-and anti-inflammatory mechanisms [11] . CD8 ϩ T cells mainly are activated to produce IFN-g, which is important for parasite control via macrophage activation and to resulting in the secretion of TNF and NO. By preventing excessive production of IFN-g and, possibly, TNF and NO, IL-10 (secreted among others by CD4 ϩ T cells) may maintain the balance between pathogenic and protective immune responses during T. brucei brucei infection.
